Effects of genistein, a tyrosine kinase inhibitor, on platelet functions: Genistein attenuates thrombin-induced Ca2+ mobilization in human platelets by affecting polyphosphoinositide turnover
- 3 August 1993
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 46 (3) , 395-403
- https://doi.org/10.1016/0006-2952(93)90515-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- [31] Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinasesPublished by Elsevier ,1991
- Role of platelet membrane glycoprotein IIb-IIIa in agonist-induced tyrosine phosphorylation of platelet proteins.The Journal of cell biology, 1990
- Effect of genistein, a tyrosine kinase inhibitor, on U46619-induced phosphoinositide phosphorylation in human plateletsBiochemical and Biophysical Research Communications, 1990
- Vasopressin dependent tyrosine phosphorylation of a 38 kDa protein in human plateletsBiochemical and Biophysical Research Communications, 1990
- Role of phosphoinositides in transmembrane signaling.Physiological Reviews, 1990
- Platelet tyrosine-specific protein phosphorylation is regulated by thrombin.Molecular and Cellular Biology, 1988
- Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphateNature, 1988
- The Metabolism of Phosphoinositide-Derived Messenger MoleculesScience, 1986
- Inositol trisphosphate and diacylglycerol as second messengersBiochemical Journal, 1984
- Production of diglyceride from phosphatidylinositol in activated human platelets.Journal of Clinical Investigation, 1979